Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice

Ye, Dewei, Wang, Yudong, Li, Huating, Jia, Weiping, Man, Kwan, Lo, Chung Mau, Wang, Yu, Lam, Karen S.L., Xu, Aimin·2014·Hepatology
DOI 10.1002/hep.27060

Cited by (184)

Items 101–184 of 184

  1. Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction
    Saurabh G. Vispute, Pengli Bu, Yuan Le, Xingguo Cheng · 2017 · Toxicology
  2. Fibroblast growth factors 19 and 21 in acute liver damage
    Zhao Shan, Gloria Álvarez‐Sola, Iker Uriarte, María Arechederra, Maite G. Fernández‐Barrena, Carmen Berasain, Cynthia Ju, Matias Antonio Avila · 2018 · Annals of Translational Medicine
  3. The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression
    Yoon Seok Jung, Ji-Min Lee, Don‐Kyu Kim, Yong Soo Lee, Ki-Sun Kim, Yong‐Hoon Kim, Jina Kim, Myung‐Shik Lee, In‐Kyu Lee, Seong Heon Kim et al. · 2016 · PLoS ONE
  4. Ameliorative effect of Lactobacillus rhamnosus GG on acetaminophen-induced hepatotoxicity via PKC/Nrf2/PGC-1α pathway
    Hend M. Ahmed, Hanan Hussien Shehata, Gamila S.M. El-Saeed, Hoda Hassan Abou Gabal, Sherien M. El‐Daly · 2022 · Journal of Genetic Engineering and Biotechnology
  5. Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice
    Sungjoon Cho, Ashutosh Tripathi, George Edward Chlipala, Stefan J. Green, Hyun Woo Lee, Eugene B. Chang, Hyunyoung Jeong · 2017 · PLoS ONE
  6. Sting mutation attenuates acetaminophen-induced acute liver injury by limiting NLRP3 activation
    Zichen Li, Fangfang Xu, Jiang‐Tao Fu, Shen-Xi Ouyang, Qi Cao, Yu-Ying Yan, Dongjie Li, Fu‐Ming Shen, Min Ni · 2023 · International Immunopharmacology
  7. FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis
    Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen et al. · 2023 · Acta Pharmaceutica Sinica B
  8. Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators
    Maria Arconzo, Elena Piccinin, Antonio Moschetta · 2020 · Digestive and Liver Disease
  9. Non-cytotoxic concentrations of acetaminophen induced mitochondrial biogenesis and antioxidant response in HepG2 cells
    Tingfen Zhang, Qiang Zhang, Jiabin Guo, Haitao Yuan, Hui Peng, Lan Cui, Jian Yin, Zhang Li, Jun Zhao, Jin Li et al. · 2016 · Environmental Toxicology and Pharmacology
  10. Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway
    Zhenzhen Zhang, Tiantian Yao, Nan Zhao, Hui Liu, Hao Cheng, Frank J. Gonzalez, Hua Wang, Guiqiang Wang, Aijuan Qu, Yan Wang · 2022 · International Journal of Biological Sciences
  11. Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR
    Yssa Rodriguez, Jack Dunfield, Tyson Roderique, Hong‐Min Ni · 2022 · Liver Research
  12. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury
    Grigorios Christidis, Ersin Karataylı, Rabea A. Hall, Susanne Nicole Weber, Matthias Reichert, Mathias Hohl, Sen Qiao, Ulrich Boehm, Dieter Lütjohann, Frank Lammert et al. · 2021 · International Journal of Molecular Sciences
  13. Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARαPAC mice due to dysregulated bile acid synthesis
    Huixin Liu, Ying Chuan Hu, Samuel William French, Frank J. Gonzalez, Yu‐Jui Yvonne Wan · 2015 · Oncotarget
  14. Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
    Yeboah Kwaku Opoku, Zhihang Liu, Justice Afrifa, Asare Kwame Kumi, Han Liu, George Ghartey‐Kwansah, Harriet Koranteng, Xinghao Jiang, Guiping Ren, Deshan Li · 2020 · EXCLI journal
  15. Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs
    Pengfei Xu, Yingjie Zhang, Xinghao Jiang, Junyan Li, Liying Song, Mir Hasson Khoso, Yunye Liu, Qiang Wu, Guiping Ren, Deshan Li · 2016 · PLoS ONE
  16. Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome
    Katarzyna J. Siemienowicz, Klaudia Furmanska, Panagiotis Filis, Chiara Talia, Jennifer L. Thomas, Paul Fowler, Mick T. Rae, William Colin Duncan · 2021 · Molecular and Cellular Endocrinology
  17. Temporal analysis of paracetamol-induced hepatotoxicity
    Aline Meireles Coelho, Isabela Ferreira Queiroz, Wanderson Geraldo de Lima, André Talvani, Luíza Oliveira Perucci, Melina Oliveira de Souza, Daniela Caldeira Costa · 2022 · Drug and Chemical Toxicology
  18. Self-assembled FGF21 nanoparticles alleviate drug-induced acute liver injury
    Zhiwei Huang, Hengcai Wang, ChangJu Chun, Xinze Li, Shihao Xu, Ying‐Zheng Zhao · 2023 · Frontiers in Pharmacology
  19. Sex modulates the association of fibroblast growth factor 21 with end‐stage renal disease in Asian people with Type 2 diabetes: a 6.3‐year prospective cohort study
    Jianjun Liu, Si Liu, Robin Wai Munn Choo, Shiou Liang Wee, A Xu, Su Chi Lim · 2018 · Diabetic Medicine
  20. Oridonin ameliorates acetaminophen‐induced acute liver injury through ATF4/PGC‐1α pathway
    Dongsheng Yu, Jiye Li, Yu Wang, Danfeng Guo, Xiaodan Zhang, Mingming Chen, Zheng Zhou · 2022 · Drug Development Research
  21. Expression of fibroblast growth factor 21 in patients with biliary atresia
    Dawei Li, Tianfei Lu, Conghuan Shen, Yuan Liu, Jiang Zhang, Yuhua Shan, Yi Luo, Zhifeng Xi, Bijun Qiu, Qimin Chen et al. · 2016 · Cytokine
  22. Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
    Panos G. Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana E. Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia E Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G. Habeos · 2016 · PLoS ONE
  23. The progress and challenges in metabolic research in China
    Li ming Xu, Ren Hao, Guangang Gao, Linkang Zhou, Muhammad Moin Ud Din Arshad, Peng Li · 2016 · IUBMB Life
  24. Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver
    Yuan Le, Liming Chen, Yue Zhang, Pengli Bu, Guoli Dai, Xingguo Cheng · 2017 · Toxicological Sciences
  25. Polysaccharides From Pogostemon cablin (Blanco) Benth.: Characterization and Antioxidant Activities
    Lei Zhao, Lei Wang, Zimeng Guo, Ning Zhang, Qisheng Feng, Bo Li · 2022 · Frontiers in Pharmacology
  26. Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2
    Pranav Kumar Prabhakar, Gaber El‐Saber Batiha · 2023 · Current Medicinal Chemistry
  27. Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study
    Massoud Houshmand, Vahide Zeinali, Amirhossein Hosseini, Atena Seifi, Bardia Danaei, Sharareh Kamfar · 2023 · Frontiers in Molecular Biosciences
  28. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review
    Cristina Elena Negroiu, Iulia Tudorașcu, Maria Cristina Beznă, Adrian Ungureanu, Sorina Octavia Honţaru, Suzana Dănoiu · 2024 · Romanian Journal of Morphology and Embryology
  29. FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data
    Chrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, Ioannis Goulis, Emmanouil Sinakos · 2025 · Current Pharmaceutical Design
  30. Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases
    Yeboah Kwaku Opoku, Zhihang Liu, Justice Afrifa, Mir Hassan Khoso, Guiping Ren, Deshan Li · 2019 · International Journal of Peptide Research and Therapeutics
  31. Unveiling the power of microenvironment in liver regeneration: an in-depth overview
    Yuelei Hu, Ruilin Wang, Ni A. An, Chen Li, Qi Wang, Yannan Cao, Chao Li, Juan Liu, Yunfang Wang · 2023 · Frontiers in Genetics
  32. A strategy for oral delivery of FGF21 for mitigating inflammation and multi-organ damage in sepsis
    Xinze Li, Dedong Yu, Xuanhe Chen, Zhiwei Huang, Ying‐Zheng Zhao · 2024 · International Journal of Pharmaceutics
  33. Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du · 2025 · Frontiers in Endocrinology
  34. PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure
    Elena Piccinin, Simon Ducheix, Claudia Peres, Maria Arconzo, Maria Carmela Vegliante, Anna Ferretta, Elena Bellafante, Gaetano Villani, Antonio Moschetta · 2019 · Scientific Reports
  35. Transgenic mice producing the trans 10, cis 12-conjugated linoleic acid present reduced adiposity and increased thermogenesis and fibroblast growth factor 21 (FGF21)
    Yu Rao, Shili Li, Meijuan Li, Baozhu Wang, Yangyang Wang, Lu-Wen Liang, Shuai Yu, Zongping Liu, Sheng Cui, Kemian Gou · 2023 · The Journal of Nutritional Biochemistry
  36. NRF2-Mediated Gene Regulation and Glucose Homeostasis
    Yoko Yagishita, Akira Uruno, Masayuki P. Yamamoto · 2016 · Elsevier eBooks
  37. The adiponectin‐derived peptide ALY688 protects against the development of metabolic dysfunction‐associated steatohepatitis
    Zhe Ping Huang, Hye Kyoung Sung, Xingqun Yan, Shiyu He, Leigang Jin, Qin Wang, Xuerui Wu, Henry H. Hsu, Angelica Pignalosa, Kathryn S. Crawford et al. · 2024 · Clinical and Translational Science
  38. Fructose Protects Against Acetaminophen‐Induced Hepatotoxicity Mainly by Activating the Carbohydrate‐Response Element‐Binding Protein α–Fibroblast Growth Factor 21 Axis in Mice
    Deqiang Zhang, Sujuan Wang, Erin Ospina, Omar Shabandri, Daniel S. Lank, Jephte Yao Akakpo, Zifeng Zhao, Meichan Yang, Jun Wu, Hartmut Jaeschke et al. · 2021 · Hepatology Communications
  39. Fibroblast Growth Factor 21 Reduces Cholesterol-Induced Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3C Signaling Pathway in LX2 Cells
    Reza Afarin, Hossein Babaahmadi‐Rezaei, Hamid Yaghooti, Narges Mohammadtaghvaei · 2021 · Hepatitis Monthly
  40. Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway
    Chuanren Zhou, Xiaomin Pan, Lei Huang, Tianzhen Wu, Tiantian Zhao, Jie Qi, Jiamin Wu, Alan Vengai Mukondiwa, Yuli Tang, Yongde Luo et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  41. The emerging role of fibroblast growth factor 21 in diabetic nephropathy
    Song Mao, Xianguo Ren, Jianhua Zhang · 2016 · Journal of Receptors and Signal Transduction
  42. A phospholipase D2 inhibitor, CAY10594, ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis
    Sung Kyun Lee, Geon Ho Bae, Ye Seon Kim, Hyung Sik Kim, Mingyu Lee, Jaewang Ghim, Brian A. Zabel, Sung Ho Ryu, Yoe‐Sik Bae · 2019 · Scientific Reports
  43. Astaxanthin Prevented Acute Alcoholic Cardiomyopathy by Maintenance of Mitophagy‐Mediated Mitochondrial Homeostasis
    G. W. Fan, Tinghao Liu, Xuemei Chen, Yan Guo, Xuan Li, Yue He, Peng Hua, Xiufei Lin, Dini Lin, Xiaoqing Yan et al. · 2025 · Journal of Cellular and Molecular Medicine
  44. A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes
    Bahar Kiani, Sahar Yarahmadi, Mohsen Nabi‐Afjadi, Hanie Eskandari, Maryam Hasani, Zahra Abbasian, Elham Bahreini · 2022 · Clinical Diabetology
  45. Fibroblast growth factor 21 alleviates acetaminophen induced acute liver injury by activating Sirt1 mediated autophagy
    Guangsen Xu, Feng Xian Qiu, Wenshu Zhang, Supeng Li, Jiale Chen, Guiyun Wang, Ye Wang, Jingye Pan, Xuebo Pan · 2024 · Cellular Signalling
  46. Fibroblast Growth Factor 21: Mechanisms, Therapeutic Potential, and Clinical Translation in Metabolic Dysfunction
    Kaanthi Rama, Vinay Jahagirdar, Arun Jayant Sanyal · 2026 · Drug Design Development and Therapy
  47. Nuciferine protects bovine hepatocytes against free fatty acid–induced oxidative damage by activating the transcription factor EB/peroxisome proliferator-activated receptor γ coactivator 1 alpha pathway
    Zhiyuan Fang, Xiuhuan Jiang, Shu Wang, Wenjun Tai, Qianming Jiang, Juan J. Loor, Hao Qiang Yu, Xue Hao, Meng Chen, Qi Shao et al. · 2023 · Journal of Dairy Science
  48. Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
    Xiaokun Li, Zhiheng Rao, Wenhao Hu, Weiqin Lu, Yongde Luo · 2024 · Obesity Reviews
  49. Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
    Wouter Vankrunkelsven, Steven Thiessen, Sarah Derde, Ellen Vervoort, Inge Derese, Isabel Pintelon, Hanne Matheussen, Alexander Jans, Chloë Goossens, Lies Langouche et al. · 2023 · Skeletal Muscle
  50. Herbo-vitamin medicine Livogrit Vital ameliorates isoniazid induced liver injury (IILI) in human liver (HepG2) cells by decreasing isoniazid accumulation and oxidative stress driven hepatotoxicity
    Acharya Balkrishna, Vivek Gohel, Meenu Tomer, Rishabh Dev, Anurag Varshney · 2024 · BMC Complementary Medicine and Therapies
  51. Nicotinamide adenine dinucleotide attenuates acetaminophen-induced acute liver injury via activation of PARP1, Sirt1, and Nrf2 in mice
    Cuiting Liao, Li Zhang, Rong Jiang, Hu Da, Juanjuan Xu, Kai Hu, Shifang Jiang, Longhui Li, Yongqiang Yang, Jiayi Huang et al. · 2022 · Canadian Journal of Physiology and Pharmacology
  52. Large-cell neuroendocrine carcinoma of nasal cavity and paranasal sinuses after successful curative therapy: a case report and literature review
    Qin Zhao, Jinlong Wei, Chengbin Zhang, Lingbin Meng, Bin Wang, Ling Gao, Xin Mei Jiang · 2019 · OncoTargets and Therapy
  53. Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside
    Yeping Huang, Bin Liu, Cheng Hu, Yan Lu · 2025 · Protein & Cell
  54. Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential
    Mariam Alamgir, Aalam Sohal, Kris V. Kowdley · 2026 · Drug Design Development and Therapy
  55. Fructose as a novel nutraceutical for acetaminophen (APAP)-induced hepatotoxicity
    Kyle Rodrigues, Rawdat Hussain, Sarah Cooke, Gary Zhang, Deqiang Zhang, Lei Yin, Xin Tong · 2023 · Metabolism and Target Organ Damage
  56. High expression of fibroblast growth factor-21 in liposarcoma patients indicated better prognosis and less recurrence
    Yingbiao Lou, Yanyan Ma, Hong Li, Yufei Song, Xue‐Song Zhang, Hong Lin, Zhang Xie, Jin Ling · 2018 · Biochemical and Biophysical Research Communications
  57. Pumpkin seed oil improves hepatotoxicity in rats through inhibition of CYP2E1 and activation of Nrf2 signaling pathways
    Noran W. Esmail, Sawsan M. El-sheikh, Reda M.S. Korany, Arwa A. Hassan, Sara M. Baraka, Hanan M. Alharbi, Ayman K. Ismail, Doaa A. Mansour, Heba Hassan H. Mahboub, Esraa.M. Fahmy · 2025 · Tissue and Cell
  58. FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
    Ewa Szczepańska, Piotr Glinicki, Wojciech Zgliczyński, Jadwiga Slowinska-Srzednicka, Helena Jastrzębska, Małgorzata Gietka‐Czernel · 2022 · Frontiers in Endocrinology
  59. Molecular hydrogen mitigates acetaminophen-induced liver injury and enhances the effects of N-acetylcysteine in diabetic mice
    Naomi Kamimura, Katsuya Iuchi, Tsutomu Igarashi, Ikuroh Ohsawa, Chikako Nito, Jitsuo Usuda, Shigeo Ohta · 2025 · The Journal of Nutritional Biochemistry
  60. Relationship Between Adipose Tissue and Liver Dysfunction in Women with Polycystic Ovary Syndrome and Metabolic Syndrome
    Sebastião Freitas de Medeiros, Gustavo Arantes Rosa Maciel · 2026 · Metabolites
  61. Hepatocyte-Specific Deficiency of BAP31 Amplified Acetaminophen-Induced Hepatotoxicity via Attenuating Nrf2 Signaling Activation in Mice
    Jie Zhao, Xiaotong Lv, Yan Huo, Xiaodi Hu, Xiaochen Li, Shizhuo Sun, Xin Zhao, Xuewei Kong, Jialin Xu · 2021 · International Journal of Molecular Sciences
  62. Endocrinology and metabolism
    Xiaokun Li · 2024 · Elsevier eBooks
  63. Targeting Nrf2 in oxidative liver injury: Expanding the role of gut microbiota and metabolites
    Yusha Luo, Yican Jiang, Tingting Zhou · 2026 · Journal of Advanced Research
  64. Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication
    Filippo Biagi, Francesco Carlomagno, Martina Iurato Carbone, Roberta Veralli, Umberto Vespasiani Gentilucci, Elisabetta Riva, Silvia Manfrini, Dario Tuccinardi, Adriano De Santis, Lucio Gnessi et al. · 2023 · Metabolites
  65. Growth factors reviews
    Xiaokun Li · 2024 · Elsevier eBooks
  66. Therapeutic Potential of FGF21 in Alzheimer’s Disease
    Anbang Sun, Benke Xu, Xianwang Wang, Lian Liu, Yun He, Zongwen Wang, Yuncai Chen · 2017 · Yangtze Medicine
  67. Mice Lacking FXR Are Susceptible to Liver Ischemia-Reperfusion Injury
    Yuxin Li, Rui‐Hua Xu, Prahlad Rao, Charles Gomes, E. Richard Moran, Michelle Puchowicz, Eugene B. Chang, D. Yin, Joseph F. Pierre · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Effect of Fibroblast Growth Factor 21 on the Expression of TLR4 and BAMBI Genes in Cholesterol-Treated Human Hepatic Stellate Cells
    Elham Shakerian, Narges Mohammadtaghvaei, Zohre Askari, Reza Afarin · 2021 · Jentashapir Journal of Cellular and Molecular Biology
  69. [Methods of molecular epidemiology of infections caused by group B streptococci].
    A V Dmitriev, E. Shakleina · 2003 · PubMed
  70. Effects of Growth Factors and Cytokines on the Liver Regeneration Phase of DILI
    亚利 魏 · 2022 · Advances in Clinical Medicine
  71. Diabetes mellitus type-2: The panoramic view of potential therapeutic targets
    A Anuradha, Amit Mittal, Shivani Sharma · 2023 · AIP conference proceedings
  72. Signaling pathway and pharmacology
    Xiaokun Li · 2024 · Elsevier eBooks
  73. The FGF metabolic axis
    Xiaokun Li · 2024 · Elsevier eBooks
  74. Adaptive mechanisms modulating acetaminophen hepatotoxicity
    Hong‐Min Ni, Wen‐Xing Ding, Anup Ramachandran, Hartmut Jaeschke · 2024 · Elsevier eBooks
  75. Research progress on regulation of mitochondrial function by traditional Chinese medicine in alleviating acetaminophen-induced liver injury
    Shuang Xia, Rong Cao, Zhiyu Hu, Jiayi Liu, Xiaoxiang Fan, Zhichao Jiang, Hui Gong, Miao Yan · 2024 · Precision medication.
  76. Immune infiltration and protective roles of FGF21 in liver injury, obesity, and hepatocellular cancer
    A. Olajuyin, C. Elferink, Casey W. Wright · 2025 · Discover medicine
  77. The value of fibroblast growth factor 21 (FGF21) promoter methylation in the repair and regeneration during the course of chronic hepatitis B
    Xue Li, Ying Zhang, Jihui Li, Tong Gang Zhao, Yu‐Chen Fan, Shuai Gao, Kai Wang · 2025 · Frontiers in Cell and Developmental Biology
  78. Fibroblast growth factor 21 (FGF21) promoter methylation drives the progression of chronic hepatitis B by mediating oxidative stress and inflammatory immunity
    Xue Li, Feng Zhang, Hanxu Zhu, Zhezhe Tian, Miaomiao Xu, Yu‐Chen Fan, Shuai Gao, Kai Wang · 2025 · Microbiology Spectrum
  79. Additional file 1 of Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
    Wouter Vankrunkelsven, Steven Thiessen, Sarah Derde, Vervoort, Ellen, Derese, Inge, Isabel Pintelon, Hanne Matheussen, Jans, Alexander, Goossens, Chloë, Lies Langouche et al. · 2024 · Figshare
  80. Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy
    Xinyu Tan, Man Li, Zhibin Lan, Wenxiang Zhang, Junjie Zou, Yibo An, Jingwen Zheng, Xuwen Xiang, Jing Lin, Sheng Lin et al. · 2026 · Acta Pharmaceutica Sinica B
  81. PLGA nanoparticles encapsulating fibroblast growth factor 21 alleviate acetaminophen-induced acute liver injury
    Jie Lin, Guoxin Jin, Ling Zhang, Xiu Weng, Kecheng Wu · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  82. Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
    Thaïs Carbinatti · 2024 · theses.fr (ABES)
  83. Valsartan alleviates acetaminophen-induced hepatotoxicity by activating fibroblast growth factor 21 in acute liver injury in mice
    Junwei Zheng, Bingyan Han, S M Wang, Lingjia Dong, Jiajia Jin, Kaicheng Wang, Darong Hai, Mina Yang, Yanyan Xu, Jingye Pan et al. · 2026 · Biochemical Pharmacology
  84. Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
    Zara Siu Wa Chui, Yaqian Xue, Xiaoping Wu, Aimin Xu · 2026 · Pharmacological Reviews